GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction - Wikidata - awgldk - TriplyDB

GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction

GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction

http://www.wikidata.org/entity/Q41816016

about

GSK-3 as potential target for therapeutic intervention in cancer Gsk3 Signalling and Redox Status in Bipolar Disorder: Evidence from Lithium Efficacy GSK3beta in ethanol neurotoxicity The role of GSK3beta in the development of the central nervous system Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice.Human neural progenitors express functional lysophospholipid receptors that regulate cell growth and morphology Issues associated with the use of phosphospecific antibodies to localise active and inactive pools of GSK-3 in cells Rho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acid GSK3beta: role in therapeutic landscape and development of modulators.Adrenergic signaling regulates mitochondrial Ca2+ uptake through Pyk2-dependent tyrosine phosphorylation of the mitochondrial Ca2+ uniporter Mitigation of carbon tetrachloride-induced hepatic injury by methylene blue, a repurposed drug, is mediated by dual inhibition of GSK3β downstream of PKA.Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.Glycogen synthase kinase-3beta plays a pro-apoptotic role in beta-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes: Role of beta1 integrins.FAK/PYK2 promotes the Wnt/β-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3β.Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications.Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo.Calcium signalling and psychiatric disease: bipolar disorder and schizophrenia.Regulation of Wnt/β-catenin signaling by posttranslational modifications The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain.Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1.Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3β activation.Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3β and ΔNp63.Proteomic and microarray analyses of the Dictyostelium Zak1-GSK-3 signaling pathway reveal a role in early development.Tyrosine phosphorylation-mediated signaling pathways in dictyostelium Dependence of NMDA/GSK-3β mediated metaplasticity on TRPM2 channels at hippocampal CA3-CA1 synapses.Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.

P2860

Q27013811-577D67A2-D084-4368-88B9-AF3D500E1FD9 Q28078551-A1C98A7F-3A2E-4A26-BE9D-7F2D6E26CC5E Q28387181-4ED5CC43-FD0B-4F40-A077-00F918A1356B Q28387853-B51B4F48-6DB8-4894-8A6A-59472622BFEA Q30464459-71E2C884-6F8A-4E18-A127-1A03F4EA2024 Q30485433-A3F0CA2B-6249-4371-A281-F9F46F5B35B4 Q30498191-C07550B5-C5C2-427C-94BF-66AB7E98B82A Q30538666-CB19C765-55AF-4E32-BC9D-BB748DE5DB1A Q33812730-D64C3657-27D4-40BB-A589-AC49F1FA6C74 Q33974822-450CFB6E-E25E-4A54-8A11-4BE948E6AA36 Q34570776-FAE93D94-165D-4D02-BBF1-4E4716A45D8B Q35551835-7C085A3F-A057-44BB-A5BE-6E6B20F62D6B Q35847201-27BEBBBB-5F40-4A59-9B79-7829A35363A1 Q36023053-1561357C-0ECB-4CF2-9F5E-839A7BDA4C3A Q36481051-A4C2B95D-DFE7-4EAF-B474-F559C85FA0AC Q36719022-9BC822BF-F90F-48D3-A856-77BD96D8BBF2 Q36954083-CE34D664-3614-4712-A971-83110D2FC567 Q37718461-78D6DCC1-0B6B-4DD2-B899-7E5CE56F702B Q38191819-FB43D8E3-3594-4FA8-9B44-D1DDD1C91FBE Q38193259-E8890968-BADB-4DC8-B039-3BDDA3739800 Q38259593-BEBDF8C1-CEEF-4889-8134-3F96A3498CC7 Q39109776-7098CD37-0FCC-4CF9-98E7-27584E420082 Q39557258-2C372D8C-CB06-4152-B658-84434976FF37 Q39612057-39DA4B69-85E5-4D94-BB8B-C131BEC0B431 Q41883884-354F14A4-53E7-4A81-922E-681ECBFC3C95 Q41890392-B1C36031-C5F9-4D6C-899C-DDA87F16433D Q41996583-5513BE8E-9C4C-41E2-8CAF-400C050D925F Q50138252-AB8ED035-5FDE-4993-A1EA-15DAEDBB01B5

P2860

GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction

http://www.wikidata.org/entity/Q41816016

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction

@en

type

label

GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction

@en

prefLabel

GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction

@en

P1433

Q41816016-D03B2C4B-5D36-4D05-BBCC-90231B737073

P1476

Q41816016-FAB13F16-955B-467A-9E95-B18A94D6FB0E

P2093

Q41816016-67A91528-ED21-48D9-8A2A-199A3CFD951E

Q41816016-684FFF69-06F3-4911-8A36-E8F5AF8137D7

Q41816016-CCCC7803-766E-4CF7-BD90-636309C222DE

Q41816016-E2A93C1F-A37F-4501-8B23-DA69FC0EA582

P2860

Q41816016-040209DC-AA30-4A5A-94FF-CBF66BAA433B

Q41816016-0EEA7398-277A-483A-8BC3-2C9E065477FA

Q41816016-10EFCF0B-52A2-45ED-BFD9-32D11C0D4C3B

Q41816016-12FB5516-AB3B-436B-AC1D-AF1A98DFF37C

Q41816016-18AD2563-FF2E-41C5-9595-599FD1C3FE90

Q41816016-18D55F42-DC6C-47F4-847A-E98E8D49B207

Q41816016-22AC8EDF-E594-4718-BE2A-B74F1678E91E

Q41816016-29CB6663-427E-4121-BCE3-38C8D3296A3C

Q41816016-30F351FA-DA5D-4E58-B65A-5FA90ADE075E

Q41816016-325A6A53-607B-4EA3-AE30-6601D2461BE3

P304

Q41816016-F18210C4-D20A-48F8-8F9C-163B6E354143

P31

Q41816016-01394F8E-0F76-4912-819B-88366057468F

P356

Q41816016-A5B02A11-B04E-4480-839A-6AD597BE4193

P433

Q41816016-3B8FA550-628D-4150-B99B-2C09EE1ADD22

P478

Q41816016-4C54BD54-CE35-439B-BB0E-A5F1FEDAA49D

P577

Q41816016-C0CDA503-9394-461D-B909-BF35B076334C

P698

Q41816016-E7AFF310-A312-43DD-A4CD-227804F47C71

P921

Q41816016-B0439191-9C5A-494B-99D6-EEB91C6213DB

P932

Q41816016-A99643CD-7423-42D6-9F27-0DD398E98D1B

P356

MBC.E05-07-0688

P1433

Molecular Biology of the Cell

P1476

GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction

@en

P2093

Aafke Ariaens

http://www.w3.org/2001/XMLSchema#string

Bas Ponsioen

http://www.w3.org/2001/XMLSchema#string

C Laura Sayas

http://www.w3.org/2001/XMLSchema#string

Wouter H Moolenaar

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A

Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions

A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation

Activation of a novel calcium-dependent protein-tyrosine kinase. Correlation with c-Jun N-terminal kinase but not mitogen-activated protein kinase activation

Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.

p116Rip targets myosin phosphatase to the actin cytoskeleton and is essential for RhoA/ROCK-regulated neuritogenesis

GSK-3: tricks of the trade for a multi-tasking kinase

Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature

P304

1834-1844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1091/MBC.E05-07-0688

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16452634

http://www.w3.org/2001/XMLSchema#string

P921

P932

1415316

http://www.w3.org/2001/XMLSchema#string